GlassScriptPhysician profile
Paul Tien
NPI 1134792070
$1,723.43
in general payments reported to CMS, 2019-2025
22 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $233 · 2022: $553 · 2023: $246 · 2024: $343 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.94 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $349.28 | 2021-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $224.08 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $198.99 | 2021-2023 | Erleada |
| Boston Scientific Corporation | $139.61 | 2023 | |
| Convatec INC. | $114.70 | 2021-2023 | |
| Urovant Sciences INC | $113.71 | 2021-2022 | |
| Pfizer INC. | $109.95 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $97.98 | 2022 | |
| Dendreon Pharmaceuticals LLC | $56.75 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $46.42 | 2022 | |
| Checkpoint Surgical, INC | $40.74 | 2024 | Checkpoint Stimulators |
| 180 Medical, INC. | $37.95 | 2021 | |
| Tolmar, INC. | $29.30 | 2025 | Eligard, Jatenzo |
| Bayer Healthcare Pharmaceuticals INC. | $25.79 | 2021-2022 | |
| Ambu INC. | $19.60 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $19.40 | 2025 | Trelstar |
| Smith+Nephew, INC. | $19.10 | 2024 | Stravix Pl, Oasis |
| Endo USA, INC. | $18.41 | 2024 | Aveed, Xiaflex |
| Antares Pharma, INC. | $16.89 | 2023 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $15.58 | 2021 | |
| Innovation Technologies INC | $15.02 | 2025 | Irrisept |
| Myriad Genetic Laboratories, INC. | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Tien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.